Victor Diaz Becomes Angiotech Vice President

Published: Tuesday, March 27, 2007 - 22:00

(Angiotech Pharmaceuticals Inc., Vancouver) -- Angiotech Pharmaceuticals Inc., global specialty pharmaceutical and medical device company, recently announced the appointment of Victor Diaz as senior vice president, global manufacturing and supply chain management.

“With his significant accomplishments in manufacturing and supply chain operations in health care and the medical device industries, we are pleased to welcome Victor to Angiotech’s senior management team,” says Dr. William Hunter, president and CEO of Angiotech.

Diaz has more than 20 years of experience in the health care, medical device and medical instruments industries. He brings to Angiotech a solid background in global manufacturing, Six Sigma, procurement, distribution, supply chain, lean manufacturing, inventory management, and ISO and FDA regulations and compliance.

“As we anticipate more growth in the future, we believe that Victor will lend his experience to align Angiotech’s people and manufacturing resources, build out our supply chain strategy, develop best practices across all of our facilities, and increase manufacturing and operational productivity,” adds Dr. Hunter.

Prior to joining Angiotech, Diaz was vice president of global operations at Teleflex Medical, the medical device and instrument manufacturing division of Teleflex Corp. During his career at Teleflex, Diaz led a staff of 4,200 people and was responsible for the global manufacturing, procurement, distribution and complete supply chain with 25 plants and 23 distribution centers in 10 countries in Europe, Asia, Latin America and the United States. Diaz also spent three years at Tyco Healthcare Respiratory, where he was vice president of manufacturing responsible for 11 manufacturing facilities in five countries.

Prior to joining Tyco Respiratory, Diaz was vice president of manufacturing for Kendall Healthcare, a subsidiary of Tyco Healthcare that manufactured disposable medical products, where he was responsible for 4,000 employees at FDA-compliant ISO- and EN-certified plants in Europe, Mexico, Venezuela, Malaysia, Thailand and the United States.

For more information, visit www.angiotech.com/news/press-releases/pdf/2007/03-07-2007_DiazAnnouncement_FINAL.pdf.

Quality Digest does not charge readers for its content. We believe that industry news is important for you to do your job, and Quality Digest supports businesses of all types.

However, someone has to pay for this content. And that’s where advertising comes in. Most people consider ads a nuisance, but they do serve a useful function besides allowing media companies to stay afloat. They keep you aware of new products and services relevant to your industry. All ads in Quality Digest apply directly to products and services that most of our readers need. You won’t see automobile or health supplement ads.

Our PROMISE: Quality Digest only displays static ads that never overlay or cover up content. They never get in your way. They are there for you to read, or not.

So please consider turning off your ad blocker for our site.

Thanks,
Quality Digest

About The Author

Quality Digest

For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.

Search

Quality Digest